Ab­b­Vie walks away from Mor­phic deal in af­ter­math of safe­ty sig­nal in pre­clin­i­cal test­ing

Ab­b­Vie is break­ing off its en­tire col­lab­o­ra­tion with Mor­phic Ther­a­peu­tic around oral in­te­grin in­hibitors, just months af­ter the phar­ma gi­ant al­ready cut away parts of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER